NCT01629849View on ClinicalTrials.gov

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
HealthyAsthma
Interventions
DRUG

Placebo to BI 1021958 qd

tablet

DRUG

BI 1021958 bid

tablets

DRUG

Placebo to BI 1021958 bid

tablets

DRUG

BI 1021958 qd

tablet

Trial Locations (1)

Unknown

1310.2.1 Boehringer Ingelheim Investigational Site, Gauting

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01629849 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects | Biotech Hunter | Biotech Hunter